|
|
Substance Name: Carbachol [USP:INN:BAN:JAN]
RN: 51-83-2
UNII: 8Y164V895Y
InChIKey: AIXAANGOTKPUOY-UHFFFAOYSA-N
Note
- A slowly hydrolyzed cholinergic agonist that acts at both muscarinic and nicotinic receptors.
Molecular Formula
- C6-H15-N2-O2.Cl
Molecular Weight
- 182.65
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Formulas
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
Classification Codes
- Analgesics
- Analgesics, Non-Narcotic
- Autonomic Agents
- Cardiotonic Agents
- Cardiovascular Agents
- Central Nervous System Agents
- Cholinergic (Ophthalmic)
- Cholinergic Agents
- Cholinergic Agonists
- Drug / Therapeutic Agent
- Human Data
- Miotics
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Protective Agents
- Sensory System Agents
Superlist Classification Code
- Threshold Planning Quantity (TPQ) = 500/10000 lb
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Carbachol
- Carbachol chloride
- Carbachol [USP:INN:BAN:JAN]
MeSH Heading
- Carbachol
Synonyms
- (2-Carbamoyloxyethyl)trimethylammonium chloride
- (2-Hydroxyethyl)trimethyl ammonium chloride carbamate
- (2-Hydroxyethyl)trimethylammonium chloride carbamate
- 2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride
- 2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride
- Carbach
- Carbachol
- Carbachol chloride
- Carbachol hydrochloride
- Carbacholin
- Carbacholine
- Carbacholine chloride
- Carbacholini chloridum
- Carbacholinium chloratum
- Carbacholinum
- Carbacholum
- Carbacholum chloratum
- Carbacholum [INN-Latin]
- Carbacol
- Carbacol [INN-Spanish]
- Carbacolina
- Carbacolo
- Carbacolo [DCIT]
- Carbamic acid, ester with choline chloride
- Carbaminocholine chloride
- Carbaminoylcholine chloride
- Carbamiotin
- Carbamoylcholine chloride
- Carbamoylcholine-hydrochloride
- Carbamylcholine chloride
- Carbastat
- Carbochol
- Carbocholin
- Carbocholine
- Carbyl
- Carcholin
- Choline carbamate chloride
- Choline chloride, carbamate
- Choline chloride, carbamoyl-
- Choline chlorine carbamate
- Choline, chloride carbamate(ester)
- Choline, chloride, carbamate, hydrochloride
- Coletyl
- Doryl
- Doryl (pharmaceutical)
- Doryl (VAN)
- EINECS 200-127-3
- Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-, chloride
- Ethanaminium, 2-(aminocarbonyl)oxy-N,N,N-trimethyl-, chloride
- gamma-Carbamoyl choline chloride
- HSDB 6373
- Isopto Carbachol
- Jestryl
- Karbachol
- Karbachol [Czech]
- Karbamoylcholin chlorid
- Karbamoylcholin chlorid [Czech]
- Lentin
- Lentine
- Lentine [French]
- Miostat
- Mistura C
- Moryl
- NSC 32865
- P. V. Carbachol
- Rilentol
- TL 457
- UNII-8Y164V895Y
- Vasoperif
Systematic Names
- Carbachol
- Choline, chloride, carbamate
- Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-, chloride
- Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-, chloride (1:1)
Superlist Name
- Carbachol chloride
Registry Numbers
CAS Registry Number
- 51-83-2
FDA UNII
- 8Y164V895Y
System Generated Number
- 0000051832
Molecular Formulas
Molecular Formula
- C6-H15-N2-O2.Cl
Molecular Formula Fragments
- C6-H15-N2-O2
- Cl
- COMPONENT
Structure Descriptors
InChI
InChI=1S/C6H14N2O2.ClH/c1-8(2,3)4-5-10-6(7)9;/h4-5H2,1-3H3,(H-,7,9);1HInChIKey
AIXAANGOTKPUOY-UHFFFAOYSA-NSmiles
[Cl-].C[N+](C)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | oral | 3mg/kg (3mg/kg) | GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS GASTROINTESTINAL: NAUSEA OR VOMITING | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 164, Pg. 346, 1932. |
dog | LDLo | subcutaneous | 100ug/kg (0.1mg/kg) | GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS GASTROINTESTINAL: NAUSEA OR VOMITING GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 164, Pg. 346, 1932. |
frog | LDLo | unreported | 5mg/kg (5mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE CARDIAC: OTHER CHANGES | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 164, Pg. 346, 1932. |
guinea pig | LDLo | subcutaneous | 75ug/kg (0.075mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 164, Pg. 346, 1932. |
human | TDLo | intramuscular | 6ug/kg (0.006mg/kg) | SKIN AND APPENDAGES (SKIN): SWEATING: OTHER VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE | Scalpel. Vol. (36), Pg. 1, 1933. |
man | TDLo | intramuscular | 2857ng/kg (0.002857mg/kg) | VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 113, Pg. 79, 1933. |
man | TDLo | intravenous | 1428ng/kg (0.001428mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION | Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 113, Pg. 79, 1933. |
mouse | LD50 | intraperitoneal | 50ug/kg (0.05mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Farmakologiya i Toksikologiya Vol. 20(4), Pg. 32, 1957. |
mouse | LD50 | intravenous | 300ug/kg (0.3mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. | |
mouse | LD50 | oral | 15mg/kg (15mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. | |
mouse | LD50 | subcutaneous | 3mg/kg (3mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. | |
rat | LD50 | intraperitoneal | 2mg/kg (2mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS BEHAVIORAL: EXCITEMENT AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 560, 1964. |
rat | LD50 | intravenous | 100ug/kg (0.1mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. | |
rat | LD50 | oral | 40mg/kg (40mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. | |
rat | LD50 | subcutaneous | 4mg/kg (4mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 210 dec | deg C | EXP | |
log P (octanol-water) | -3.780 | (none) | EST | |
Atmospheric OH Rate Constant | 2.27E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.